The main category of All News Articles.
You can use the search box below to find what you need.
[wd_asp id=1]
The main category of All News Articles.
You can use the search box below to find what you need.
[wd_asp id=1]
Two major research reviews just answered a question I get asked constantly: What is the best diet for people with MS?
Diet and nutrition can have a huge impact on symptom worsening, disability progression, and overall quality of life. And we now have solid evidence showing which dietary approaches work best.
In this blog, I’ll walk you through two important meta-analyses on diet and multiple sclerosis. The first one examined how adding a Mediterranean diet to a common MS medication affects relapse rates and disability. The second compared eight different diets head-to-head to see which ones actually reduced fatigue and improved quality of life.
Before we dive into the findings, let me explain what makes these studies so powerful.
A meta-analysis is a research technique that pools results from multiple studies to get a clearer picture of whether an intervention actually works. Instead of relying on just one small study, researchers use a systematic strategy to find all the studies that meet their pre-defined criteria. Then, two independent researchers review each study to confirm the results and check for bias. They use statistics to analyze the combined data and create what’s called a 95% confidence interval.
If the 95% confidence interval falls entirely on the side favoring the intervention, you can confidently say that the intervention in question is genuinely helpful for that specific outcome.
Now let’s look at what two recent meta-analyses revealed about diet and MS.
This meta-analysis looked specifically at randomized controlled studies that combined a Mediterranean diet with one particular disease-modifying treatment (DMT) — dimethyl fumarate, also known by the brand name Tecfidera.
Because different MS medications can affect relapse rates and new brain lesions in different ways, having everyone in these studies on the same medication reduces a major source of variation. It makes it much easier to see what the diet itself is contributing.
The researchers included seven randomized controlled studies with a total of 1,118 participants with relapsing-remitting MS. Most of the studies were conducted in Iran (five studies), with one in Sweden and one in Turkey. They looked at three specific outcomes: annual relapse rate, disability progression (measured by something called the Expanded Disability Status Scale, or EDSS), and quality of life scores.
Three studies involving 468 people examined relapse rates. The results showed that people who adopted a Mediterranean diet while taking dimethyl fumarate had a 31% lower risk of relapse compared to those on the medication alone. The statistical analysis was extremely strong — you can confidently say that combining the Mediterranean diet with this medication further reduces relapse risk beyond what the medication does on its own.
Four studies with 650 participants measured disability using the EDSS scale. Those who followed a Mediterranean diet showed significantly less disability progression compared to the control group. Again, the confidence interval clearly favored the diet intervention.
This is where things get interesting. Three studies involving 503 people measured quality of life using a standard MS assessment tool that looks at both physical health and mental health. The Mediterranean diet did not show statistically significant improvements in either physical or mental quality of life scores.
So the Mediterranean diet helped with relapse rates and disability progression, but not with how people actually felt day-to-day. Keep that finding in mind as we look at the next study.
This earlier meta-analysis used a different approach called a network meta-analysis, which allows researchers to compare three or more interventions simultaneously. This is powerful because you can not only see which diets work, but also rank them against each other to see which ones work best.
Dr. Snetselaar and her team found 12 randomized diet studies involving 608 participants. They compared eight different dietary approaches: Paleolithic, Low-fat, Mediterranean, Fasting, Calorie Restriction, Ketogenic, Anti-inflammatory, and a Control diet. The outcomes they measured were fatigue and quality of life (both physical and mental).
Because the 12 studies used different assessment tools to measure fatigue and quality of life, the researchers had to standardize the results using something called a standardized mean difference (SMD) with a 95% confidence interval. The key thing to look for: if the confidence interval falls entirely on the side of the diet intervention, that diet likely helps with the outcome being measured.
Three diets showed clear benefits for reducing fatigue compared to control:
The Ketogenic diet also reduced fatigue, but the confidence interval wasn’t strong enough to draw solid conclusions. Fasting and Anti-inflammatory diets had minimal impact on fatigue.
Here’s an important finding: The Calorie Restriction diet actually made fatigue significantly worse.
For improving physical quality of life, two diets stood out:
Paleolithic diet (SMD 1.01)
Mediterranean diet (SMD 0.47)
Paleolithic diet (SMD 0.81)
Mediterranean diet (SMD 0.36)
The Ketogenic and Low-fat diets showed some improvements in both physical and mental quality of life, but the confidence intervals weren’t strong enough to draw firm conclusions. Calorie Restriction, Fasting, and Anti-inflammatory diets didn’t improve quality of life.
I’m excited to see more dietary intervention studies being conducted in MS research. Our own study at the University of Iowa, “Efficacy of Diet on Quality of Life,” will complete its last study visit in July 2026, and we’ll likely be presenting findings at MS conferences in 2027.
But here’s what we can learn from these two meta-analyses right now:
The first study showed that adding a Mediterranean diet to dimethyl fumarate (Tecfidera) further reduced relapse risk and disability progression beyond what the medication achieved alone. That’s significant.
Let me explain how this medication works, because it connects to how diet helps. Dimethyl fumarate activates something called the nuclear factor erythroid 2 related factor (Nrf2) pathway, which then inhibits another pathway called nuclear factor kappa B (NF-kappa B).(3) This blocks inflammation-producing molecules like TNF-alpha, IL-1, and IL-6, which calms excessive inflammation and reduces the risk of relapses and new brain lesions.
Dimethyl fumarate is as potent as many of the infusion medications. But here’s the exciting part: adding better nutrition amplified its benefits even more.
The second study — the network meta-analysis — revealed something crucial: not all diets are equally effective for MS symptoms.
The Paleolithic and Mediterranean diets came out on top for reducing fatigue and improving quality of life. The Paleolithic diet was roughly 30% more effective than Mediterranean for reducing fatigue, and about twice as effective for improving both physical and mental quality of life.
This helps explain the puzzle from the first study. The Mediterranean diet reduced relapses and disability progression but didn’t significantly improve quality of life scores. The network meta-analysis suggests that while Mediterranean helps, Paleolithic may be more effective for how you actually feel day-to-day.
You can stimulate that same Nrf2 pathway that dimethyl fumarate activates by eating significantly more non-starchy vegetables and berries. This is exactly what both Mediterranean and Paleolithic diets emphasize — lots of colorful plant foods.
I believe part of the mechanism behind why these diets work is through activating the Nrf2 pathway naturally through food. When you eat foods rich in certain plant compounds, you’re essentially getting some of the same anti-inflammatory benefits as the medication, but from your plate.
Have a family meeting and discuss how you could add more green leafy vegetables and berries to your weekly meals. This is important enough to make it a household priority, not just something you tackle alone.
If you’re working with a healthcare provider who prescribes dimethyl fumarate, consider adopting a Mediterranean or Paleolithic diet alongside it. The evidence suggests this combination can be particularly powerful.
You don’t have to rely solely on prescription medications to boost the Nrf2 pathway. Several natural compounds can stimulate Nrf2 and inhibit NF-kappa B, including pterostilbene, curcumin, glucoraphanin (from broccoli sprouts), and epigallocatechin-3-gallate (from green tea).(4-6) These compounds are included in Cytokine Modulator.
I also encourage people with MS to ensure their vitamin D levels are in the top half of the reference range. Get outside. Get some sun exposure without getting sunburned. And take both vitamin D3 and vitamin K2 together. Vitamin K2 is important because it helps facilitate myelin repair and supports getting calcium into your teeth and bones where it belongs.
There’s a lot you can do to support your healing journey, and this research confirms that dietary choices can make a meaningful difference in both disease progression and how you feel.
Polkadot price predictions are raising eyebrows, Cardano is making headlines in a major way, and Remittix just dropped word of a $30 million mega announcement.
The buzz around top DeFi projects is alive and kicking, and today’s headlines are flashing red-hot for three names: Polkadot (DOT), Cardano (ADA) and the newcomer Remittix.
Better still, the broader crypto market is hinting at renewed momentum for early stage crypto investment and next big altcoin narratives. For anyone who wants to catch the ride and avoid standing on the sidelines, this is the moment.
When analysts call a project the next big altcoin in 2025, you take notice and that’s exactly what’s happening with Polkadot. Some Polkadot price-prediction models see DOT climbing well above current levels by end of year. One forecast puts DOT’s range between $8.42 and a staggering $61.63 in 2025.

Considering DOT is trading near $3.25 at present and up 10.12% in the last week. This implies a potential leap – which fuels the urgency: you either position now, or watch others jump ahead. The underpinning case is strong: Polkadot’s parachain architecture supports a cross-chain DeFi project model, boosting its utility and making it a strong contender in the ‘high growth crypto 2025’ label.
However, not all forecasts agree. Some sources estimate as low as $2.50-$3.20 range for the rest of the year. This means risk is still real. If Polkadot fails to trigger breakout catalysts or the market turns sour, it may languish.
Over at Cardano, the headlines are buzzing. Analysts recently projected a 100-150% rally in the coming weeks, if momentum holds. A golden cross in ADA’s chart and rising volume also jump out.

Meanwhile, update after update: ADA recently surged to near $0.91 after breaking a long-term triangle pattern. The project has solid fundamentals, solid community support, and healthier trading activity. Whale accumulation is being flagged too.
But for investors tuned into top altcoins to invest in, Cardano is flashing warning signs of missing out. If you believe in an undervalued crypto project with serious upside and smart community support, ADA continues to tick boxes.
Enter Remittix. With the market’s eye on traditional DeFi heavyweights, this young contender is carving a niche in real-world utility: crypto to fiat bank account payments in 30+ countries. The $28 million raised in private funding speaks volumes – demand is proven.
Now the $30 million mega announcement looms as a catalyst event. This is not hype for hype’s sake; investors are viewing it as the kind of moment that separates the ‘could have’ from the ‘did’.
While Polkadot and Cardano fight for position in crowded ecosystems, Remittix is operating in payment rails, bridging crypto and fiat – a niche still under-penetrated. Its growth potential is labelled by some as the next 100x crypto.
If you’re chasing the best crypto to buy now and want exposure to the movement before mainstream sees it, Remittix is shouting at volume.
Discover the future of PayFi with Remittix by checking out their project here:
Website: https://remittix.io/
Socials: https://linktr.ee/remittix
$250,000 Giveaway: https://gleam.io/competitions/nz84L-250000-remittix-giveaway
Disclaimer: This content has been supplied by a third party contributor. Brave New Coin does not endorse or promote any products or services mentioned herein. Readers are encouraged to conduct independent research before making any financial decisions. The information provided is for informational and educational purposes only and should not be interpreted as investment advice.
November is National Family Caregivers Month.
Lymphedema is a build-up of a watery fluid in your body called lymph, causing chronic swelling, usually in an arm or leg. Lymph, which supports your overall health and your immune system function, flows from your tissues into the lymphatic vessels, and then through a cluster of nodes (lymph nodes) that filter out bacteria and other unwanted substances.
If any of the lymph nodes are removed or damaged as part of cancer treatment, the remaining nodes have to work harder to filter the lymph. They can then become inflamed or even blocked, so the lymph backs up into the tissue.
There’s no cure for lymphedema, but if you’re actively involved with your partner’s medical care, it’s helpful to know what you can do to help him manage the condition.There are actions you can take to help reduce your partner’s swelling, prevent infection, relieve discomfort and help improve their mobility.
“We want to make sure the [caregiver] is also aware of what’s going on, so that they can help with either massaging and helping the spouse, or arranging some ways of getting care,” said Pragnan Kancharla, MD, a medical oncologist and hematologist at MedStar Franklin Square Medical Center in Maryland.
Speaking with a specialized lymphedema specialist is helpful. But not everyone has access to one.
If your partner does develop lymphedema, it’s important to understand how you can help.
Where lymphedema occurs depends on where the affected lymph nodes are. For people with prostate cancer, lymphedema could affect the legs, penis, scrotum or lower body overall.
Symptoms of lymphedema could include:
A radical prostatectomy, which removes the prostate and pelvic lymph nodes, is the most common cause of lymphedema among people who have prostate cancer. Radiation sometimes damages the nodes too. Men who have both surgery and radiation therapy are at higher risk of lymphedema, and the more nodes affected, the higher the risk.
Lymphedema could also be caused by:
Diagnosing and starting treatment for lymphedema in the early stages can slow down its progress. Moderate to severe swelling can make it hard to walk and perform everyday activities.
The simple act of elevating the affected leg can be quite helpful, Kancharla said. And doing some simple exercises can also help. Exercises move the lymph and encourage good range of motion around the joints — something that could become difficult if there is too much swelling.
A healthcare provider (HCP), physical therapist or lymphedema specialist can show you and your partner the best exercises to do. Many can even be done while sitting down.
Some exercises that are good for lymphedema include:
Here are some other tips you could assist your partner with to help reduce the swelling caused by lymphedema:
.
If the first steps at home don’t work, there are other options. Your partner’s HCP can also refer him to other healthcare professionals, like occupational or physical therapists.
Exercises, doing lymphatic massages and eating a healthy diet are things that most people can do at home, but not everyone can easily afford lymphatic massages done at a clinic or office, compression stockings, or pumps. Medicare does cover lymphedema compression treatment items though, as do some private insurance companies. Private insurance might also cover massages. It’s important that your partner apply for assistance if he needs it.
With you and your partner working as a team, you can help lessen anxiety and stress for both of you. By understanding your partner’s condition and treatment, you can also act as his advocate if necessary. “Lymphedema [with prostate cancer] is extremely rare now, something that we don’t see as often,” Kancharla said. “But if someone does have lymphedema, especially related to the tumor or cancer itself or post-surgery, we do have a lot of resources.”
This educational resource was created with support from Bayer and Merck.
From Your Site Articles
Related Articles Around the Web
The Web3 gaming sector is experiencing a whirlwind of developments this week, as highlighted in a recent update from CoinMarketCap, sparking significant interest among cryptocurrency traders. With GameFi tokens facing downward pressure despite gaming accounting for 28% of decentralized application (DApp) activity, investors are closely monitoring potential trading opportunities in this volatile niche. The panic induced by a YouTube ban on certain content has amplified market jitters, yet positive funding news like Tatakai securing $7 million from heavyweights such as Tencent, Yield Guild Games (YGG), and Immutable is providing some counterbalance. This influx of capital could signal bullish reversals for related tokens, urging traders to watch support levels around key GameFi assets like those tied to Immutable’s ecosystem.
Despite the bleeding prices in GameFi tokens, the sector’s robust underlying metrics suggest a potential mismatch between market sentiment and fundamentals. According to the CoinMarketCap thread dated November 10, 2025, Web3 gaming commands a substantial 28% of all DApp activity, indicating strong user adoption that could drive long-term value. Traders should note that this high engagement contrasts with recent price dips, possibly creating buying opportunities at discounted levels. For instance, if we consider trading pairs like IMX/USDT on major exchanges, historical data shows that funding rounds often precede volatility spikes. With Tatakai’s $7 million raise from Tencent and others, expect increased trading volumes in related pairs, potentially pushing resistance levels higher if bullish momentum builds. Market indicators such as the Relative Strength Index (RSI) for GameFi indices might hover near oversold territories, signaling a rebound as institutional interest grows.
Moonfrost’s strategic pivot to Steam represents a bridge between traditional gaming and Web3, which could expand liquidity for associated tokens and attract mainstream investors. This move, as noted in the CoinMarketCap update, might correlate with upticks in on-chain metrics for projects integrating with platforms like Immutable. Traders focusing on cross-market opportunities should analyze how such pivots influence broader crypto sentiment, especially in relation to stock market trends in gaming giants like Tencent. Meanwhile, TAC Protocol is gaining traction amid the sector’s challenges, with its developments potentially cooking up new trading narratives. On-chain data could reveal rising transaction volumes, offering insights into accumulation phases. For those eyeing short-term trades, monitoring 24-hour price changes in GameFi baskets against Bitcoin (BTC) or Ethereum (ETH) pairs is crucial, as sector bleeds often lead to capitulation followed by sharp recoveries.
From a broader trading perspective, the YouTube ban panic underscores regulatory risks in the crypto gaming space, advising caution in position sizing. However, with 28% DApp dominance, GameFi remains a hotspot for institutional flows, potentially mirroring stock market rallies in tech sectors. Traders might explore correlations with AI tokens if Web3 gaming incorporates more intelligent features, but the core focus should be on verifiable metrics like daily active users and token velocities. As the week unfolds, keeping an eye on support at recent lows and resistance near all-time highs could uncover profitable entries. Overall, this mix of challenges and milestones positions GameFi for dynamic trading action, blending risk and reward in the evolving cryptocurrency landscape.
Delving deeper into trading strategies, the sector’s bleed despite strong fundamentals invites analysis of market indicators for reversal signals. For example, if GameFi tokens like those from YGG experience volume surges post-funding, traders could target breakouts above moving averages. The $7 million Tatakai investment from Tencent, announced on November 10, 2025, via CoinMarketCap, might catalyze similar inflows, boosting pairs such as YGG/USDT. Institutional participation often leads to reduced volatility over time, making these assets appealing for swing trades. Additionally, Moonfrost’s Steam integration could enhance token utility, driving demand and potentially lifting prices amid broader market recoveries. In terms of cross-asset correlations, GameFi’s performance might echo stock movements in entertainment firms, offering hedged positions against crypto downturns.
To optimize trading decisions, consider on-chain metrics like total value locked (TVL) in gaming protocols, which remain resilient at 28% DApp share. This data point, from the recent CoinMarketCap insights, suggests underlying strength that could counterbalance the current token bleeds. For risk management, setting stop-losses below key support levels is advisable, especially with external factors like the YouTube ban introducing uncertainty. Long-term holders might view this as a dip-buying phase, aligning with trends in decentralized finance (DeFi) where gaming intersects. As Web3 evolves, integrating real-time sentiment analysis tools could help predict shifts, ensuring traders stay ahead in this high-stakes arena.
Matcha, a Japanese green tea leaf that’s stone-ground into a very fine powder and often used as a meditative practice, has gained international popularity. Variations of the trendy drink have made their way into cafes, restaurants and even personal kitchens, especially in the US.
Traditionally, matcha is mixed with warm water, making it fairly simple to prepare. The practice dates back hundreds of years in Chinese and Japanese culture, and there are a few tricks of the trade that will help you make the perfect drink.
We spoke with Japanese tea master Yoshitsugu Nagano to learn everything you need to know. We also got his views on Americanizing the drink by adding milk, sweeteners and additional mix-ins.
The primary requirement is a high-quality matcha powder (see our testing in the link above). There are also a handful of items you’ll need to enjoy matcha in your morning routine.
A bamboo whisk and bowl: To make matcha the traditional way, you’ll want to start with a bamboo whisk, also known as a chasen, and a small bowl that fits comfortably in your hands (I use this one).
“Reserve [the bowl] for matcha only,” said Nagano, who hosts traditional tea rituals in New York City. “As you drink daily from the same bowl, you’ll feel your body, the bowl and the tea becoming one.”
You will also want to make sure you don’t use a bowl made from a material that emits too much heat, such as metal or porcelain.
A sifter and an electric kettle: You’ll also need a sifter and an electric kettle. You can use a stovetop kettle instead if you already have one on hand, but we recommend an electric kettle so that you can control the water temperature, which is crucial when making matcha (more on this below).
There are also full matcha kits available for those who prefer to purchase everything together.
A milk frother: If you want to make lattes, a milk frother will be your friend. You can also use a handheld milk frother to whisk your matcha if you don’t plan on purchasing a bamboo whisk.
A sweetener and milk: You can also add any sweeteners or milks you’d like to use. Some popular options are simple syrup, honey and agave.
Nagano said that although “there isn’t a single right or wrong way to whisk matcha,” there are certain steps you can take to enhance “its meditative effect.”
As you may have already assumed, the best time to make matcha is typically in the mornings.
“Historically, matcha rituals developed as samurai meditation, and records show many samurai hosted early-morning tea gatherings,” Nagano said. “Since matcha contains caffeine, it’s well-suited to starting the day.”
Before beginning the tea ritual, you’ll want to find an area in your home where you feel calm or “any place that lets you step a little outside daily life,” Nagano said. Align your posture and take deep breaths to help you relax. Then you can begin.
Pour a small amount of warm water from your kettle into the bowl and soak your whisk for about 30 seconds. Soaking your whisk will help soften it and prevent it from breaking. When you’re done, discard that water and dry your bowl.
You don’t need a fancy sifter to get the job done.
Sift half a teaspoon of matcha powder into your bowl and add about four tablespoons of water to the bowl
“Add water along the side of the bowl rather than pouring directly onto the powder to avoid splashing and clumping,” Nagano said.
For matcha, your water should be right around 80 degrees Celsius (176 degrees Fahrenheit). Any temperature above 70 degrees Celsius (158 degrees Fahrenheit) could cause your matcha to become bitter or diminish the foam.
“Foam matters because it greatly affects flavor perception,” Nagano said. “Drinks with foam — champagne, beer, lattes and matcha — release aromatic compounds when bubbles burst in the mouth.”
A bamboo whisk is a must-have if you’re planning on making matcha traditionally.
The correct way to hold your whisk is with your thumb, index and middle fingers in an upright position.
“Move in straight lines and be sure your path passes through the center of the bowl,” Nagano said. “This creates complex currents whose collisions generate fine foam. Avoid tracing the bowl’s inner wall in circles; that method won’t produce satisfying foam.”
Aim to go back and forth with your wrist about 50 times.
After the powder is fully dissolved and you have a thick, deep green liquid, it’s ready.
“Before drinking, settle your posture and your breathing and clear your mind,” Nagano said. “Lift the bowl gently with both hands and bow in gratitude and respect to the matcha and to nature. Then sip slowly.”
As you slowly drink your matcha, pay attention to the warmth of the drink as it goes through your body, and your attention will turn “inward to body and mind,” he said.
If you want to make matcha lattes instead of drinking it in the traditional sense, you can add extra ingredients. Nagano supports drinking it however you please. Although he practices the traditional matcha ritual detailed above, he believes the “classics and modern styles elevate each other’s existence and value.”
Frothers will help add extra flavor and foam to your lattes.
Nagano explained that matcha originated in China during the Northern Song Dynasty about 1,000 years ago. It then arrived in Japan roughly 800 years ago, where it quickly gained popularity.
“The United States today is in a similar moment to Japan’s first encounter 800 years ago,” he said. “It’s conceivable that over the next few centuries, a uniquely American style of matcha ritual will take shape.”
After all, matcha isn’t the first item to spread internationally and develop in different ways. Nagano compared the continual reinvention of the historic drink to the California roll, which was invented post World War II, after sushi was introduced to the US. Later, traditional sushi styles also gained popularity. Nagano calls this “a superb example of creativity and tradition connecting without contradiction.”
Today, you’ll see matcha lattes served over ice, with flavors like strawberry and mango added in. Matcha desserts, such as my newfound favorite cookies, are also gaining popularity, and matcha cocktails are emerging on the scene.
Baking with matcha may be my new favorite hobby.
Nagano sees the ongoing diversification of the tea-based drink as positive. “It’s wonderful when different cultures meet and something new emerges,” he said.
The XRP price prediction is once again the talk of the market as traders eye a potential 400% surge. While XRP continues to make headlines, investors are also turning to Remittix https://remittix.io, the PayFi project that has raised over $28 million through the sale of 684 million tokens at $0.1166 each. With exchange listings, wallet testing, and ecosystem rollouts underway, many now see Remittix as the smarter long-term bet.
XRP Price Prediction: Bulls Orchestrate another Huge Upruning
Following a robust 300% increase since November 2024, XRP is currently trading at just around $2.35 https://www.tradingview.com/symbols/XRPUSD/ and remains resilient to profit-taking and market uncertainty. Those who provide their current XRP price prediction anticipate that when the Ripple case concludes and presumed spot XRP ETFs are approved by a more favorable U.S. government, a significant surge to the $8 – $9 value could occur. Analysts https://x.com/ali_charts/status/1987240958765728180 have also confirmed that XRP is flashing a buy signal on its TD sequential.
Presently, the stochastic RSI is close to 30.53, where a potential reversal momentum is observed, and traders are waiting until the breakout of the price above the resistance of $2.37. The next key support sits around $2.10, where whales have been quietly accumulating. https://x.com/ali_charts/status/1987098017409720529 If momentum returns and institutional demand picks up, this XRP price prediction cycle could easily push gains back toward the 400% mark.
Remittix: The PayFi Powerhouse Stealing The Spotlight
While XRP eyes institutional growth, Remittix https://remittix.io continues to build real-world adoption through its expanding ecosystem. The project has confirmed its first two centralized exchange listings, with two more secured for upcoming milestones. The team has already passed KYC verification on CertiK and has secured the top position in the CertiK Skynet Pre-Launch leaderboard – evidence of its transparency and deep investor trust.
Remittix Wallet has been in its beta phase, and users have been able to test real-time payments of crypto-to-fiat. Its upcoming Web App will integrate global fiat support, advancing Remittix’s mission to bridge crypto and traditional finance.
Why investors are bullish on Remittix:
● Supports 30+ fiat currencies and 40+ cryptocurrencies at launch
● Built-in FX engine delivers transparent, real-time conversion rates
● Merchant pilot programs launching in top remittance corridors
● $250,000 community giveaway campaign is active until the next milestone
● Deflationary tokenomics rewards holders and stabilizes supply
Why RTX Might Be The Better Bet
The XRP price prediction shows optimism, but Remittix https://remittix.io is building tangible products and real-world connections. XRP may lead in liquidity, yet RTX leads in innovation, offering a bridge between blockchain and everyday payments. As investors hunt for the next 100x crypto with real utility, Remittix is positioning itself as the clear front-runner for 2025’s DeFi revolution.
Discover the future of PayFi with Remittix by checking out their project here:
Website: https://remittix.io/
Socials: https://linktr.ee/remittix
$250K Giveaway: https://gleam.io/competitions/nz84L-250000-remittix-giveaway
Disclaimer: This article is for informational purposes only and does not constitute financial advice. Cryptocurrency investments carry risk, including total loss of capital. Readers should conduct independent research and consult licensed advisors before making any financial decisions.
Crypto Press Release Distribution by https://btcpresswire.com
This release was published on openPR.
November is National Family Caregivers Month.
Lymphedema is a build-up of a watery fluid in your body called lymph, causing chronic swelling, usually in an arm or leg. Lymph, which supports your overall health and your immune system function, flows from your tissues into the lymphatic vessels, and then through a cluster of nodes (lymph nodes) that filter out bacteria and other unwanted substances.
If any of the lymph nodes are removed or damaged as part of cancer treatment, the remaining nodes have to work harder to filter the lymph. They can then become inflamed or even blocked, so the lymph backs up into the tissue.
There’s no cure for lymphedema, but if you’re actively involved with your partner’s medical care, it’s helpful to know what you can do to help him manage the condition.There are actions you can take to help reduce your partner’s swelling, prevent infection, relieve discomfort and help improve their mobility.
“We want to make sure the [caregiver] is also aware of what’s going on, so that they can help with either massaging and helping the spouse, or arranging some ways of getting care,” said Pragnan Kancharla, MD, a medical oncologist and hematologist at MedStar Franklin Square Medical Center in Maryland.
Speaking with a specialized lymphedema specialist is helpful. But not everyone has access to one.
If your partner does develop lymphedema, it’s important to understand how you can help.
Where lymphedema occurs depends on where the affected lymph nodes are. For people with prostate cancer, lymphedema could affect the legs, penis, scrotum or lower body overall.
Symptoms of lymphedema could include:
A radical prostatectomy, which removes the prostate and pelvic lymph nodes, is the most common cause of lymphedema among people who have prostate cancer. Radiation sometimes damages the nodes too. Men who have both surgery and radiation therapy are at higher risk of lymphedema, and the more nodes affected, the higher the risk.
Lymphedema could also be caused by:
Diagnosing and starting treatment for lymphedema in the early stages can slow down its progress. Moderate to severe swelling can make it hard to walk and perform everyday activities.
The simple act of elevating the affected leg can be quite helpful, Kancharla said. And doing some simple exercises can also help. Exercises move the lymph and encourage good range of motion around the joints — something that could become difficult if there is too much swelling.
A healthcare provider (HCP), physical therapist or lymphedema specialist can show you and your partner the best exercises to do. Many can even be done while sitting down.
Some exercises that are good for lymphedema include:
Here are some other tips you could assist your partner with to help reduce the swelling caused by lymphedema:
.
If the first steps at home don’t work, there are other options. Your partner’s HCP can also refer him to other healthcare professionals, like occupational or physical therapists.
Exercises, doing lymphatic massages and eating a healthy diet are things that most people can do at home, but not everyone can easily afford lymphatic massages done at a clinic or office, compression stockings, or pumps. Medicare does cover lymphedema compression treatment items though, as do some private insurance companies. Private insurance might also cover massages. It’s important that your partner apply for assistance if he needs it.
With you and your partner working as a team, you can help lessen anxiety and stress for both of you. By understanding your partner’s condition and treatment, you can also act as his advocate if necessary. “Lymphedema [with prostate cancer] is extremely rare now, something that we don’t see as often,” Kancharla said. “But if someone does have lymphedema, especially related to the tumor or cancer itself or post-surgery, we do have a lot of resources.”
This educational resource was created with support from Bayer and Merck.
From Your Site Articles
Related Articles Around the Web
Gold surged to $4,085 per ounce, extending last week’s recovery as investors priced in a near 70% chance of a December rate cut by the Federal Reserve. The rally comes amid weakening U.S. labor data, falling consumer sentiment, and signs of a possible end to the historic government shutdown — a combination that’s undermining the U.S. Dollar Index (DXY) and pushing safe-haven demand sharply higher.
The Senate’s 60–40 vote to reopen federal agencies reduced near-term political risk while triggering broad risk-on flows across markets. Yet, gold’s strength shows investors are betting that fiscal relief will lead to a weaker dollar and renewed liquidity — a classic setup that supports precious metals.
Fresh macro data from October revealed deep cracks in the U.S. job market. Over 150,000 layoffs were reported, marking the largest October job-cut total in over two decades. Meanwhile, the University of Michigan Consumer Sentiment Index plunged to 50.3, the lowest since mid-2022 and well below the forecasted 53.2.
The downturn reinforced investor conviction that the Fed will deliver another 25 basis point cut at the December meeting, reducing rates to the 3.50%–3.75% range. For XAU/USD, lower rates directly translate to reduced opportunity costs, making the metal more attractive than yield-bearing assets.
Traders note that the recent slowdown in Non-Farm Payroll growth, averaging just 95,000 per month in 2025 versus 200,000+ in 2023–2024, signals fading momentum across multiple sectors. These data points continue to anchor bullish sentiment around gold, as rate-sensitive investors hedge against further U.S. economic weakness.
Central bank accumulation remains one of the most powerful undercurrents in gold’s rally. According to the World Gold Council, global central banks — led by China, India, and Turkey — have collectively added over 800 tonnes of gold in 2025 through Q3.
Emerging markets continue to diversify reserves away from U.S. Treasuries and into gold amid persistent currency volatility. This structural trend has created a floor under gold prices near the $3,900–$4,000 range, insulating the market from deeper corrections.
Institutional flows confirm similar behavior, with ETFs recording three consecutive weeks of inflows totaling over $3.1 billion. This surge reflects renewed conviction that XAU/USD remains undervalued relative to its inflation-hedge appeal and central bank hoarding pace.
Technically, gold has re-established its bullish trajectory. After bouncing off the 20-day EMA near $3,981, buyers defended the $4,000 psychological level and pushed prices toward the $4,085 zone, confirming renewed upward strength.
Key resistance now stands near $4,100–$4,130, with an extension target of $4,265, last month’s high. If momentum persists, the market could retest the October record near $4,380, before a broader advance toward $4,400–$4,500.
On the downside, immediate support is positioned at $4,025, followed by $3,900 at the 50-day EMA. Momentum indicators remain constructive — the RSI at 54 and a bullish MACD crossover signal a continued upward bias.
While the Senate’s move to end the shutdown temporarily boosts investor confidence, the fiscal implications could paradoxically support gold further. Reopened federal spending raises long-term deficit projections, adding to structural debt concerns that historically fuel gold accumulation.
Analysts emphasize that the shutdown’s resolution is not inherently bearish for gold. Although it may cause a short-lived USD bounce, broader market interpretation leans toward higher fiscal outflows, delayed growth, and lower yields — all favorable for gold’s medium-term outlook.
Traders are now watching how the Treasury market absorbs the $125 billion in new issuance this week. Should yields remain subdued despite supply expansion, XAU/USD could see another leg higher toward $4,200 before mid-November.
Markets continue to price a 64%–70% chance of a December rate cut as inflation slows and growth data weaken. Fed officials’ tone has softened, with policymakers hinting that policy tightening has achieved sufficient disinflation.
Lower real rates historically create a twofold benefit for gold: they diminish the relative yield advantage of bonds and weaken the dollar’s purchasing power. The current DXY range around 99.5 underscores fading demand for the greenback, with multiple analysts projecting further downside toward 98.7 in Q4.
The bond market reinforces this narrative — the 10-year Treasury yield (BX:TMUBMUSD10Y) holding near 4.11% reflects stable nominal yields against falling inflation expectations, creating the ideal backdrop for sustained XAU/USD strength.
Institutional traders are increasingly using bull call spreads and put-sell combinations to capture upside while managing volatility. With volatility metrics subdued and implied skew favoring calls, options desks indicate rising appetite for $4,200–$4,400 strike exposure through December.
Funds also appear to be rotating from equities into commodities — particularly gold and silver — amid valuation concerns in AI and tech sectors. Silver, gold’s industrial counterpart, has gained 1% this week, hovering near $50 per ounce with 65% year-to-date performance, reflecting broader precious metal strength.
Market data shows speculative long positions in COMEX gold futures increasing by over 8% week-on-week, the largest net build since March. These leveraged inflows align with strong ETF demand, confirming synchronized institutional optimism.
Despite the brief recovery in risk assets, the dollar-devaluation trade remains the key macro narrative supporting gold. Analysts highlight persistent deficits, rising interest costs, and expanding debt-to-GDP ratios as the primary long-term drivers for gold’s appreciation.
Experts warn that even a temporary delay in the next rate cut won’t derail the bullish thesis, as the underlying real yield compression and fiscal imbalance maintain structural support for precious metals.
Forecasts from leading institutions reinforce this trajectory — Goldman Sachs targets $5,055, Bank of America $5,000, and UBS $4,700 under its upside scenario by 2026. Consensus targets for Q1 2026 cluster around $4,200–$4,400, implying moderate upside but strong retention above current levels.
After analyzing labor weakness, rate expectations, central bank accumulation, and technical resilience, TradingNews maintains a decisive BUY outlook on Gold (XAU/USD). Support at $4,000 remains firm, while upside potential stretches toward $4,200–$4,400 in the short term and $5,000+ over the next 12 months.
Gold continues to stand as the preferred macro hedge in an environment of dovish monetary policy, fiscal expansion, and dollar devaluation. Unless the Fed surprises with hawkish rhetoric or DXY rebounds above 100.3, the path of least resistance remains upward.
The technical and fundamental alignment — from Fed expectations to central bank flows — confirms that gold’s bullish cycle remains intact, positioning XAU/USD as one of the most resilient trades heading into 2026.
The ongoing US government shutdown and the divergent market expectations for the future policies of the US Federal Reserve continue to heavily influence the trajectory of the US Dollar against other major currencies, as well as the rest of the global financial markets. The US government shutdown is preventing the release of US jobs figures, which are the most important economic data affecting market expectations for the future of Federal Reserve policy. In addition to that report, US inflation readings are due to be announced this week.
Prior to that, the EUR/USD pair attempted to recover from its three-month lows when it plunged to the 1.1468 support level last week, but the cautious upward rebound gains did not exceed the 1.1592 resistance level before closing the week stabilized around the 1.1560 level.
According to Forex currency trading experts’ forecasts, the bearish outlook for the EUR/USD pair was confirmed by its stabilization below the 1.1600 support. As I mentioned before, this opens the door for further downward pressure on the currency pair, which has happened. The continuation of the bearish outlook does not rule out a drop to the 1.1400 support level, especially since the technical indicators, which have turned bearish, have room to move downward before reaching the oversold zone. Currently, the 14-day Relative Strength Index (RSI) is around a reading of 44, below the neutral line, and at the same time, the MACD indicator lines are steadily leaning downward.
Conversely, on the same timeframe, the daily chart indicates a strong bullish scenario for the EUR/USD pair, requiring a move towards the psychological resistance level of 1.1800. Today’s EUR/USD trading is not focused on any major US economic releases; the only anticipated indicator is the Sentix Eurozone Consumer Confidence Index, due at 11:30 AM Cairo time.
The EUR/USD gains will remain vulnerable to rapid collapse until investor confidence returns to the market, which could happen with the end of the US government shutdown.
The future of US central bank policy is becoming increasingly uncertain.
The prospects for US monetary policy remained ambiguous following the recent wave of statements from Federal Reserve officials. Divisions among Fed policymakers persisted in the wake of last Wednesday’s US interest rate cut, raising doubts about their ability to agree on another cut at their anticipated meeting on December 9-10. While some officials openly supported further monetary easing, others expressed reluctance, if not opposition, to cutting US interest rates again next month.
In short, the overall tone of official statements on Thursday and earlier this week reinforced Federal Reserve Chair Jerome Powell’s assertion that a December US interest rate cut is “not a given.”
John Williams, President of the New York Fed, one of Powell’s most prominent aides as Vice Chair of the policy-making FOMC, had been supportive of policy easing in recent weeks to address labor market weakness, but last Thursday he limited his comments to saying the bank must adhere to its 2% inflation target and strive for “price stability.”
Meanwhile, Austin Goolsbee, president of the Federal Reserve Bank of Chicago, who voted for rate cuts in September and October, appeared less insistent on another rate cut on Thursday, particularly given the lack of economic data from the closed federal government. He saw “stabilization” in the labor market and expressed deep concern about inflation in the absence of statistics. Meanwhile, Beth Hammack, president of the Federal Reserve Bank of Cleveland, who will join the Federal Open Market Committee (FOMC) voting line next year, was more vocal in her opposition to another near-term rate cut, arguing that inflation is a greater concern than the struggling labor market and emphasizing the need for monetary policy to remain “in a fairly restrictive position to achieve the right balance of our objectives.”
Overall, for the second consecutive meeting, the FOMC lowered the US interest rate by 25 basis points on October 29 to a target range of 3.75% to 4.0%. However, in an unusually split decision, Federal Reserve Governor Stephen Miran opposed a 50-basis point cut, while Kansas City Fed President Jeffrey Schmid opposed the decision, favoring keeping rates unchanged.
In addition to this easing move, the FOMC moved faster than many expected to halt “quantitative tightening” by the end of this month. The FOMC had cut the interest rate by the same amount on September 17 to a target range of 4.0% to 4.25%. In its revised Summary of Economic Projections, published in September, FOMC participants anticipated another 25 basis points of monetary easing at the Committee’s final meeting in 2025.
Despite 25 basis points remaining in the September “dot plot,” Powell stressed in his October 29 press conference that a rate cut on December 9-10 “is not a foregone conclusion, far from it.” He noted “sharp differences in views on how to proceed in December.” He added that the FOMC has cut the federal funds rate by 150 basis points since it began easing monetary policy in September 2024, making policy now “150 basis points closer to neutral.” He added that this prompts some officials to “pause” and “wait” before easing policy further, while others wish to “move forward” with more easing.
Powell said the FOMC “will resume monetary easing at some point,” but added that it is trying to deal with a “difficult” and “complex” situation that requires “balancing” the two-sided risks—either in favor of inflation or in favor of jobs. In this climate, he said it is appropriate to be “cautious.” He added that if there is a “high degree of uncertainty” on December 10, “that might justify caution about moving.”
Ready to trade our EUR/USD daily forecast? Here’s a list of some of the top forex brokers in Europe to check out.
Iron deficiency is globally widespread. Women are particularly affected, with one in five in Europe suffering from iron deficiency. The consequences are anemia, constant fatigue, chronic headaches and a weakened immune system. Researchers led by ETH professor Raffaele Mezzenga have now developed a new dietary supplement that could efficiently treat iron deficiency and anemia. This development is being co-led by Michael B. Zimmermann, professor emeritus at ETH Zurich. The preparation consists of edible oat protein nanofibrils coated with iron nanoparticles. The corresponding study has just been published in the journal Nature Food.
The new iron compound is not only easy to produce but also extremely effective: the iron it contains is absorbed by the body almost twice as well as iron administered from iron sulphate – the currently most widely used standard for iron supplementation. This is shown by a rigorous clinical study conducted by Mezzenga’s project partners in Thailand. They administered the compound to 52 women aged 18 to 45 who were suffering from anemia due to iron deficiency.
The novel preparation has several advantages. Being based on plant proteins means that it is suitable for vegetarians and vegans. “This is important because they are more likely to suffer from iron deficiency than meat-eaters: the body absorbs iron from animal foods better than iron from plant-based foods,” says ETH professor Mezzenga.
The new compound has further advantages: it is tasteless and colourless, meaning it does not substantially alter a food’s taste or appearance. Iron sulphate, in contrast, gives food a metallic aftertaste.
“Sensory properties play a major role in consumer acceptance of food additives,” says Jiangtao Zhou, the first author of the study and Mezzenga’s former postdoctoral researcher and currently an assistant professor at the National University of Singapore. The oat protein iron supplement is also very easy to take: it can either be dissolved in water or juice, or added to food in powder form – muesli, for instance.
“However, the clinical study shows that the supplement is best absorbed when it is dissolved in water,” says Mezzenga.
Iron occurs naturally in red meat, lentils and whole grains. Premenopausal women have a particularly high iron requirement of 18 milligrams per day. The daily requirement for men is lower, at 11 milligrams. Nevertheless, around 15 percent of men also suffer from iron deficiency. To combat this, people resort to iron supplements that the body is often unable to absorb sufficiently and require iron infusions in the case of severe iron deficiency.
The researchers originally used animal proteins to develop their iron supplement process a few years ago; however, the same patent covers all food protein sources, including those that are plant based. It has by now been granted in Europe and the USA.
Mezzenga and his colleagues now hope that the iron-enriched oat protein fibres will soon be able to be used in a variety of ways. “The hurdles for launching a dietary supplement are lower than those for a pharmacological product,” explains the ETH professor, who aims to further develop the technology to combat other deficiencies, such as zinc and selenium.
Source:
Journal reference:
Zhou, J., et al. (2025). Oat protein nanofibril–iron hybrids offer a stable, high-absorption iron delivery platform for iron fortification. Nature Food. doi: 10.1038/s43016-025-01260-6. https://www.nature.com/articles/s43016-025-01260-6